Abstract
The NF2 gene product, merlin/schwannomin, is a cytoskeleton organizer with unique growth-inhibiting activity in specific cell types. A narrow spectrum of tumors is associated with NF2 deficiency, mainly schwannomas and meningiomas, suggesting cell-specific mechanisms of growth control. We have investigated merlin function in mouse Schwann cells (SCs). We found that merlin regulates contact inhibition of proliferation by limiting the delivery of several growth factor receptors at the plasma membrane of primary SCs. Notably, upon cell-to-cell contact, merlin downregulates the membrane levels of ErbB2 and ErbB3, thus inhibiting the activity of the downstream mitogenic signaling pathways protein kinase B and mitogen-activated protein kinase. Consequently, loss of merlin activity is associated with elevated levels of ErbB receptors in primary SCs. We also observed accumulation of growth factor receptors such as ErbB2 and 3, insulin-like growth factor 1 receptor and platelet-derived growth factor receptor in peripheral nerves of Nf2-mutant mice and in human NF2 schwannomas, suggesting that this mechanism could play an important role in tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bache KG, Slagsvold T, Stenmark H . (2004). Defective downregulation of receptor tyrosine kinases in cancer. EMBO J 23: 2707–2712.
Bretscher A, Edwards K, Fehon RG . (2002). ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3: 586–599.
Bringold F, Serrano M . (2000). Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 35: 317–329.
Buzard GS, Enomoto T, Anderson LM, Perantoni AO, Devor DE, Rice JM . (1999). Activation of neu by missense point mutation in the transmembrane domain in schwannomas induced in C3H/HeNCr mice by transplacental exposure to N-nitrosoethylurea. J Cancer Res Clin Oncol 125: 653–659.
Cheng HL, Steinway M, Delaney CL, Franke TF, Feldman EL . (2000). IGF-I promotes Schwann cell motility and survival via activation of Akt. Mol Cell Endocrinol 170: 211–215.
Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI . (2007). Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol 177: 893–903.
Deretic D, Traverso V, Parkins N, Jackson F, Rodriguez de Turco EB, Ransom N . (2004). Phosphoinositides, ezrin/moesin, and rac1 regulate fusion of rhodopsin transport carriers in retinal photoreceptors. Mol Biol Cell 15: 359–370.
Fernandez-Valle C, Tang Y, Ricard J, Rodenas-Ruano A, Taylor A, Hackler E et al. (2002). Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat Genet 31: 354–362.
Fraenzer JT, Pan H, Minimo Jr L, Smith GM, Knauer D, Hung G . (2003). Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation. Int J Oncol 23: 1493–1500.
Giovannini M, Robanus-Maandag E, Niwa-Kawakita M, van der Valk M, Woodruff JM, Goutebroze L et al. (1999). Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev 13: 978–986.
Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L et al. (2000). Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14: 1617–1630.
Hansen MR, Linthicum Jr FH . (2004). Expression of neuregulin and activation of erbB receptors in vestibular schwannomas: possible autocrine loop stimulation. Otol Neurotol 25: 155–159.
Hardy M, Reddy UR, Pleasure D . (1992). Platelet-derived growth factor and regulation of Schwann cell proliferation in vivo. J Neurosci Res 31: 254–262.
Hirokawa Y, Tikoo A, Huynh J, Utermark T, Hanemann CO, Giovannini M et al (2004). A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor. Cancer J 10: 20–26.
Hirschberg K, Miller CM, Ellenberg J, Presley JF, Siggia ED, Phair RD et al (1998). Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol 143: 1485–1503.
Hyun TS, Ross TS . (2004). HIP1: trafficking roles and regulation of tumorigenesis. Trends Mol Med 10: 194–199.
Itahana K, Campisi J, Dimri GP . (2004). Mechanisms of cellular senescence in human and mouse cells. Biogerontology 5: 1–10.
Jones KA, Jiang X, Yamamoto Y, Yeung RS . (2004). Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport. Exp Cell Res 295: 512–524.
Jozwiak J . (2006). Hamartin and tuberin: working together for tumour suppression. Int J Cancer 118: 1–5.
Kissil JL, Wilker EW, Johnson KC, Eckman MS, Yaffe MB, Jacks T . (2003). Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. Mol Cell 12: 841–849.
Lallemand D, Curto M, Saotome I, Giovannini M, McClatchey AI . (2003). NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev 17: 1090–1100.
Lim JY, Kim H, Kim YH, Kim SW, Huh PW, Lee KH et al. (2003). Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway. Biochem Biophys Res Commun 302: 238–245.
Lobsiger CS, Schweitzer B, Taylor V, Suter U . (2000). Platelet-derived growth factor-BB supports the survival of cultured rat Schwann cell precursors in synergy with neurotrophin-3. Glia 30: 290–300.
Maitra S, Kulikauskas RM, Gavilan H, Fehon RG . (2006). The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling. Curr Biol 16: 702–709.
Manent J, Oguievetskaia K, Bayer J, Ratner N, Giovannini M . (2003). Magnetic cell sorting for enriching Schwann cells from adult mouse peripheral nerves. J Neurosci Methods 123: 167–173.
Mary S, Charrasse S, Meriane M, Comunale F, Travo P, Blangy A et al. (2002). Biogenesis of N-cadherin-dependent cell–cell contacts in living fibroblasts is a microtubule-dependent kinesin-driven mechanism. Mol Biol Cell 13: 285–301.
McClatchey AI, Giovannini M . (2005). Membrane organization and tumorigenesis—the NF2 tumor suppressor, Merlin. Genes Dev 19: 2265–2277.
Miyake K, McNeil PL, Suzuki K, Tsunoda R, Sugai N . (2001). An actin barrier to resealing. J Cell Sci 114: 3487–3494.
Morrison H, Sperka T, Manent J, Giovannini M, Ponta H, Herrlich P . (2007). Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res 67: 520–527.
Muallem S, Kwiatkowska K, Xu X, Yin HL . (1995). Actin filament disassembly is a sufficient final trigger for exocytosis in nonexcitable cells. J Cell Biol 128: 589–598.
Nikitin A, Ballering LA, Lyons J, Rajewsky MF . (1991). Early mutation of the neu (erbB-2) gene during ethylnitrosourea-induced oncogenesis in the rat Schwann cell lineage. Proc Natl Acad Sci USA 88: 9939–9943.
Perrais M, Chen X, Perez-Moreno M, Gumbiner BM . (2007). E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol Biol Cell 18: 2013–2025.
Polo S, Pece S, Di Fiore PP . (2004). Endocytosis and cancer. Curr Opin Cell Biol 16: 156–161.
Pujuguet P, Del Maestro L, Gautreau A, Louvard D, Arpin M . (2003). Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell 14: 2181–2191.
Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR . (2004). E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J 23: 1739–1748.
Rao DS, Hyun TS, Kumar PD, Mizukami IF, Rubin MA, Lucas PC et al. (2002). Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. J Clin Invest 110: 351–360.
Sherman L, Sleeman JP, Hennigan RF, Herrlich P, Ratner N . (1999). Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitro. Oncogene 18: 6692–6699.
Siskova Z, Baron W, de Vries H, Hoekstra D . (2006). Fibronectin impedes ‘myelin’ sheet-directed flow in oligodendrocytes: a role for a beta 1 integrin-mediated PKC signaling pathway in vesicular trafficking. Mol Cell Neurosci 33: 150–159.
Stanasila L, Abuin L, Diviani D, Cotecchia S . (2006). Ezrin directly interacts with the alpha1b-adrenergic receptor and plays a role in receptor recycling. J Biol Chem 281: 4354–4363.
Stonecypher MS, Chaudhury AR, Byer SJ, Carroll SL . (2006). Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis. J Neuropathol Exp Neurol 65: 162–175.
Syroid DE, Zorick TS, Arbet-Engels C, Kilpatrick TJ, Eckhart W, Lemke G . (1999). A role for insulin-like growth factor-I in the regulation of Schwann cell survival. J Neurosci 19: 2059–2068.
Tamma G, Klussmann E, Oehlke J, Krause E, Rosenthal W, Svelto M et al. (2005). Actin remodeling requires ERM function to facilitate AQP2 apical targeting. J Cell Sci 118: 3623–3630.
Acknowledgements
We thank J Lippincott-Schwartz for the kind gift of the VSV-GFP construct, Z-Y Han for assistance with mouse genotyping, all members of the U674 lab for helpful discussions and support, L Goutebroze B Goud and O Hanemann for helpful suggestions, A McClatchey for many stimulating discussions, M Pla (Departement d’Experimentation Animale—Institut Universitaire d’Hematologie) and the Centre de Distribution, Typage et Archivage animal for mouse housing. DL personally thanks F Mechta-Grigoriou for helpful advice and discussions and continuous support and Odette Mariani for careful reading of the manuscript. This work was supported by Grants from the US Department of Defense (W81XWH-05-1-0265), Association Neurofibromatoses et Recklinghausen, Canceropôle Ile-de France, Institut National du Cancer, ANR and INSERM.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of interest
None declared.
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Rights and permissions
About this article
Cite this article
Lallemand, D., Manent, J., Couvelard, A. et al. Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas. Oncogene 28, 854–865 (2009). https://doi.org/10.1038/onc.2008.427
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.427
Keywords
This article is cited by
-
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma
Nature Communications (2023)
-
Merlin regulates signaling events at the nexus of development and cancer
Cell Communication and Signaling (2020)
-
Pathomechanisms in schwannoma development and progression
Oncogene (2020)
-
Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns
Scientific Reports (2017)
-
Identification of candidate genes for devil facial tumour disease tumourigenesis
Scientific Reports (2017)